Trinity, a Waltham, Massachusetts, company that advises pharmaceutical, biotech and medtech companies on bringing products to market, has acquired Verix, the maker of an AI-powered commercial planning platform for drugmakers called Tovana. The deal was announced on October 20, 2026.
Terms were not disclosed. Verix's entire team is joining Trinity, and Verix chief executive Doron Aspitz joins Trinity's leadership team, where he will continue to guide Tovana's product roadmap.
Existing Verix clients will keep the product, roadmap and support they use today, Trinity said. Tovana's features will be built into Trinity's TrinityEDGE software over the coming months, with the first joint offerings expected to reach clients in the first half of 2027.
What Verix built
Verix was founded in 2007 and has offices in the United States and Israel. Its patented Tovana platform is sold as software-as-a-service to pharmaceutical, biotech and specialty pharma commercial teams.
Tovana takes prescription, claims, clinical and engagement data and turns it into recommendations: which doctors a sales team should target, how to segment them, what the next best action with each one is, and which mix of channels to use. It also handles patient discovery, therapeutic landscape analysis, opportunity assessment and bottom-up forecasting, combining machine learning, agentic workflows and domain knowledge.
According to Trinity, one of the largest pharmaceutical oncology divisions in the United States raised leading indicators, including new prescriptions, by 15 to 25 percent using Tovana, and a rare oncology therapy team improved its field-facing net promoter score twelvefold. Tovana also supported the US launch of a targeted oncology immunotherapy. Verix's website lists testimonials from people at Bayer, Novartis, Kyowa Kirin and Ironshore Pharmaceuticals.
“Insight has outpaced execution. Teams are rich in disparate analysis and thin in decisive action in front of a customer. Verix closes that gap.”
Why Trinity is buying
Trinity has more than 30 years of strategy and insights work for life sciences companies and employs about 1,500 people in 14 offices on five continents. Over the past three years it has added software, data and AI under the TrinityEDGE brand.
Trinity said drugmakers have adopted AI but have not seen the payoff, because analysis rarely reaches the moment when a sales rep or brand team acts on it. Targeting lists go stale between planning cycles and reps ignore recommendations they cannot see the reasons for. Many brands also pay one vendor for insight and another for execution.
"Insight has outpaced execution. Teams are rich in disparate analysis and thin in decisive action in front of a customer. Verix closes that gap," said Scott Evangelista, Trinity's chief executive.
Trinity said the deal gives it more access to brand, field and digital buyers beyond its traditional strategy and insights relationships, and that it is setting up a dedicated AI and product development centre.
The founders and the funding
Aspitz leads Verix as chief executive. "We built Verix on one conviction: commercial teams deserve intelligence that is timely, explainable, and usable in the flow of work," he said, adding that joining Trinity was the natural next step.
Dealroom lists $13 million raised by Verix but does not name its investors, and neither company disclosed funding details or Verix's headcount. No valuation was given.
A consolidating market for pharma AI
Pharmaceutical companies spend heavily on deciding which doctors their sales forces and digital campaigns should reach, and that work is increasingly run by software rather than spreadsheets built once a quarter. Consultancies that used to sell the analysis are now buying the tools that put it into the field.
For Trinity, Verix adds a product that has been running in live deployments for years rather than a new build. For Verix, after almost two decades as a specialist vendor, the deal brings a much larger sales channel through Trinity's existing pharma clients.
Trinity did not say whether the Verix brand will continue once Tovana is folded into TrinityEDGE.
